With Growth Rates Stagnating In Developed Markets, What Is A Med-Tech Exec To Do?

Push for growth in emerging markets like Brazil, Russia, India and China (BRIC).
bric-300x2001
For some Med-Tech Companies, growth rates in emerging markets are double, triple and in some cases 10-fold those in the US and other developed markets. This trend was clearly evident as I listened to and reviewed transcripts from Q4 2012 earnings calls from Johnson & Johnson, Boston Scientific, and Medtronic.

While emerging markets continue to present significant growth opportunities, how can med-tech companies address the variety of needs and delivery models in these markets, while addressing increasing pricing pressures in developed economies?

To learn key strategies Med-Tech Executives are utilizing to push for growth in BRICs, click on this link to read the complete article.

This is an excerpt from our recently published article in MedicalDeviceSummit.

Bookmark and Share